Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLF2P4 is a human pseudogene that shares sequence similarity with Kruppel like factor 2 (KLF2), which is a member of the Kruppel-like factors (KLFs) family of zinc finger transcriptional regulators. Pseudogenes do not encode functional proteins and are generally considered non-functional remnants of duplicated or mutated genes. Kruppel like factor 2 itself is a well-studied transcription factor involved in vascular biology, immune regulation, and cell differentiation, but KLF2P4 does not produce a protein and is not recognized as a therapeutic target or biomarker. There is no evidence in current biomedical databases or the literature indicating any direct biological function, disease association, drug interaction, or therapeutic relevance for KLF2P4. The most relevant research and clinical interest centers on KLF2 and its related functional family members such as KLF4. If information on a therapeutic target is needed, KLF2 (not KLF2P4) is the canonical gene to investigate for roles in vascular inflammation, endothelial function, and related disease mechanisms. No synonyms, aliases, or alternative names for KLF2P4 appear in common biomedical usage beyond its formal gene symbol. This “target” is not a recognized protein, receptor, or therapeutic target; it is a pseudogene, and its inclusion as a drug target is likely incorrect. If you intended to inquire about KLF2 or another KLF family member, please clarify for further information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel like factor 2 pseudogene 4 (KLF2P4).